SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Studying Harms Is Key to Improving Psychedelic-Assisted Therapy—Participants Call for Changes to Research Landscape
3 references·5 citing·29 second hop
Studying Harms Is Key to Improving Psychedelic-Assisted Therapy—Participants Call for Changes to Research Landscape (2023)Studying Harms Is Key to Improving Psyche…Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression (2022)Single-Dose Psilocybin for a …Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review (2022)Adverse events in clinical tr…The Lancet Psychiatry Commission on psychological treatments research in tomorrow's science (2018)The Lancet Psychiatry Commiss…MDMA and MDMA-Assisted Therapy (2025)MDMA and MDMA-Assisted TherapyThe Psychedelic Future of Post-Traumatic Stress Disorder Treatment (2024)The Psychedelic Future of Pos…Adverse Events in Studies of Classic Psychedelics (2024)Adverse Events in Studies of …Therapeutic mechanisms of psychedelics and entactogens (2023)Therapeutic mechanisms of psy…History repeating: guidelines to address common problems in psychedelic science (2023)History repeating: guidelines…The Principles of Psychology (1891)Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication (2005)Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey Replication (2005)Reducing the global burden of depression: a Lancet–World Psychiatric Association Commission (2018)Anxiety disorders (2021)Global, regional and national burden of anxiety disorders from 1990 to 2019: results from the Global Burden of Disease Study 2019 (2021)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial (2016)A New Depression Scale Designed to be Sensitive to Change (1979)The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 (1998)Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial (2022)Single-Dose Psilocybin Treatment for Major Depressive Disorder (2023)Psilocybin desynchronizes the human brain (2024)Research Domain Criteria (RDoC): Toward a New Classification Framework for Research on Mental Disorders (2010)Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial (2016)CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials (2010)CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials (2010)Measuring the Prevalence of Questionable Research Practices With Incentives for Truth Telling (2012)Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin (2024)Psychedelic-Induced Neural Plasticity: A Comprehensive Review and a Discussion of Clinical Implications (2025)Posttraumatic Stress Disorder in the National Comorbidity Survey (1995)Relationship of Childhood Abuse and Household Dysfunction to Many of the Leading Causes of Death in Adults (1998)Why Most Published Research Findings Are False (2005)How to perform a meta-analysis with R: a practical tutorial (2019)Cochrane Handbook for Systematic Reviews of Interventions (2020)The PRISMA 2020 statement: an updated guideline for reporting systematic reviews (2021)Oxytocin increases trust in humans (2005)Psychedelics Promote Structural and Functional Neural Plasticity (2018)
this work references cited by second hop

References

  • 2022Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression1,164 cited
  • 2018The Lancet Psychiatry Commission on psychological treatments research in tomorrow's science623 cited
  • 2022Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review177 cited

Cited by

  • 2024Adverse Events in Studies of Classic Psychedelics156 cited
  • 2023History repeating: guidelines to address common problems in psychedelic science136 cited
  • 2024The Psychedelic Future of Post-Traumatic Stress Disorder Treatment80 cited
  • 2023Therapeutic mechanisms of psychedelics and entactogens71 cited
  • 2025MDMA and MDMA-Assisted Therapy62 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work